Price History
Feb 9, 2026 — Apr 4, 2026Investment Snapshot
- Trading 88% above Graham Number — above intrinsic value estimate
- Piotroski F-Score 5/9 — moderate financial health
- ROE of 21.7% — good return on equity
- Revenue growing at 10% annually
Encompass Health Corporation (EHC) is a Healthcare company operating in Services-Hospitals, listed on the NYSE , with a market capitalisation of $10.1 billion . Key value metrics: P/E ratio 19.1, P/B ratio 4.40, Piotroski F-Score 5 out of 9 (moderate financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
Encompass Health Corporation — Fundamental Analysis Summary
Encompass Health Corporation (EHC) is currently trading 88% above its Graham Number of $53.82, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries a reasonable trailing P/E ratio of 19.1x.
On financial health, EHC shows a moderate Piotroski F-Score of 5/9, and strong return on equity of 21.7% (sector average: -19.8%), and elevated leverage with a debt-to-equity ratio of 1.21.
StockPik's composite Value Score for EHC is 69/100 — an above-average value rating. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
EHC shows revenue growing at 10% year-over-year, with earnings growing at 24%.
EHC pays a modest dividend yield of 0.7%.